Clinical Trials Browser

Phase 1/2 × Terminated × Thalidomide × Clear all

NCT00971126 2016-05-04

Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular